<DOC>
	<DOCNO>NCT01154504</DOCNO>
	<brief_summary>1 . Study Hypothesis : - The decrease plasma adrenomedullin ( ADM ) concentration ultrafiltration isovolumetric hemofiltration patient acute III IV Class New York Heart Association Functional ( NYHA ) heart failure pronounce standard diuretic treatment related clinical improvement . 2 . Outcome Measurements : To correlate adrenomedullin plasma level clinical treatment , ultrafiltration hemofiltration relate : - Brain natriuretic peptide ( BNP ) level - angiotensin II level - sympathetic nervous activity - oxydative stress - clinical outcome beginning , discharge 90 day randomization .</brief_summary>
	<brief_title>The Role Adrenomedullin Outcome Severe Heart Failure : Clinical Randomized Study</brief_title>
	<detailed_description>Testing hypothesis adrenomedullin ( ADM ) important peptide severe heart failure relate clinical condition , study effect 3 different treatment ( clinical usual treatment , ultrafiltration isovolumetric hemofiltration diuretic ) participant follow discharge Adrenomedullin level clinical outcome , also relationship angiotensin II level , brain natriuretic peptide ( BNP ) , sympathetic nervous system oxydative stress . The patient randomize three different treatment group analyze three moment : randomization , discharge 90 day randomization ( plus minus 3 ) . The clinical treatment optimize , ultrafiltration do clinically adequate fluid removal hematocrit increase 10 % basal level , isovolumetric hemofiltration do 8 hours- dose 35 ml/kg/h association diuretic . All dialytic procedure do PAES membrane- filter HF1400 automatic machine .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Adrenomedullin</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>two item : eighteen year age orthopnea Chest Rx cardiomegaly pulmonary infiltration edema diuretic resistance insulin dependent diabetes hepatic cirrhosis vascular access problem creatinine 2,5 mg/dl acute heart failure systemic infection aortic stenosis heart transplantation radiologic contrast 72 hour prior randomization advance neoplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>adrenomedullin</keyword>
	<keyword>heart failure</keyword>
	<keyword>ultrafiltration</keyword>
	<keyword>hemofiltration</keyword>
</DOC>